当前位置: 首页 > 期刊 > 《健康大视野·医学分册》 > 2019年第6期
编号:13319126
坦洛新缓释片联合PKRP治疗前列腺增生合并膀胱过度活动症的疗效分析(1)
http://www.100md.com 2019年3月15日 《健康大视野》 2019年第6期
     【摘 要】目的:分析坦洛新缓释片+PKRP术疗法在前列腺增生合并膀胱过度活动症患者中的治疗效果。方法:选取83例前列腺增生合并膀胱过度活动症患者,双盲法分组,2组均采用组PKRP术进行治疗,观察组在此基础上服用坦洛新缓释片,对比2组临床效果。结果:观察组与对照组治疗总有效率(95.12%VS92.86%)不存在显著差异(P>0.05);观察组治疗后USPSS评分、VSS评分均优于对照组治疗后(P<0.05)。结论:坦洛新缓释片+PKRP术,临床效果良好。

    【关键词】前列腺增生;膀胱过度活动症;坦洛新缓释片;PKRP

    Efficacy of Tamsulosin Sustained Release Tablets Combined with PKRP in the Treatment of Prostatic Hyperplasia Complicated with Overactive Bladder

    Abstract:Objective To analyze the therapeutic effect of Tamsulosin sustained-release tablets plus PKRP in patients with benign prostatic hyperplasia and overactive bladder.Method: Eighty-three patients with benign prostatic hyperplasia complicated with overactive bladder were divided into two groups by double-blind method. Both groups were treated by PKRP. The observation group was treated with Tamsulosin sustained-release tablets on the basis of this ......
1 2下一页

您现在查看是摘要页,全文长 3429 字符